[144] Phillips 66 SEC Filing
Form 144 notice for Phillips 66 (PSX): This filing reports a proposed sale of 4,393 shares of common stock on the New York Stock Exchange through Merrill Lynch, with an aggregate market value of 615,020. The shares were acquired on 01/17/2025 as a restricted stock unit vesting from Phillips 66 and the payment/consideration is listed as compensatory. The filing lists the total number of shares outstanding as 404,124,265. Recent activity shows two prior sales by Vanessa Sutherland: 4,393 shares on 09/09/2025 for 593,055 and 4,393 shares on 07/08/2025 for 571,090.
- Full disclosure of acquisition and sale details including acquisition date, nature (RSU vest), broker, and planned sale date
- Prior sales disclosed for the same account within the past three months, showing transparency
- Insider sale reported — 4,393 shares proposed for sale which could be perceived negatively by some investors despite small size relative to outstanding shares
Insights
TL;DR: Routine insider sale of vested RSUs; transaction size is immaterial relative to outstanding shares and appears compensatory.
The filing documents a planned sale of 4,393 shares acquired via RSU vesting on 01/17/2025, executed through Merrill Lynch on the NYSE, with an indicated aggregate market value of 615,020. The sale is consistent with compensation-related dispositions rather than an extraordinary corporate event. Given the issuer's stated outstanding share count of 404,124,265, the position represents a very small fraction of the company, suggesting limited market impact. Prior small sales by the same individual in July and September 2025 are disclosed, showing a pattern of disposition of vested awards.
TL;DR: Disclosure aligns with Rule 144 requirements and includes necessary acquisition and sale details; no unusual governance issues shown.
The form provides the required elements under Rule 144: acquisition date and nature (RSU vest), broker name and planned sale date, outstanding shares, and recent sales history. The filer certifies lack of undisclosed material adverse information, and the document names the seller as Vanessa Sutherland. There is no indication in this filing of plan adoption dates, 10b5-1 trading plan reliance, nor any disclosure of material nonpublic information. The filing appears procedurally complete for the reported proposed sale.